Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01976169 |
|
Recruitment Status :
Completed
First Posted : November 5, 2013
Last Update Posted : February 8, 2022
|
Sponsor:
University of Texas Southwestern Medical Center
Collaborators:
Pfizer
University of Pennsylvania
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 19, 2021 |
| Actual Study Completion Date : | May 19, 2021 |